Trial site
Hopital Saint Eloi
- 16running trials
- 11closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis6 trials
- Acute myeloid leukaemia3 trials
- Chronic lymphocytic leukaemia2 trials
- Hodgkin lymphoma2 trials
- Kidney cancer2 trials
- Liver and biliary tract cancer2 trials
- Mantle cell lymphoma2 trials
- Myelodysplastic syndromes2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Chronic spontaneous urticaria1 trial
- Coronary artery disease1 trial
- and 6 more
- Phase
- Phase 318 trials
- Phase 26 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting12 trials
- Completed11 trials
- Recruiting4 trials
- Lead sponsor
- AbbVie4 trials
- Merck Sharp & Dohme LLC3 trials
- Abivax S.A.2 trials
- French Innovative Leukemia Organization2 trials
- Janssen Research & Development, LLC2 trials
- and 13 more
Running trials
Recruiting
A Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Mantle cell lymphoma1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026